In response to the U.S. Supreme Court’s decisions in AMP v. Myriad Genetics, 569 U.S. 12-398 (Jun. 13, 2013) and Mayo v. Prometheus, 566 U.S. 10-1150 (March. 20, 2012), the United States Patent and Trademark Office issued a memorandum on March 4, 2014, providing a guideline for determining the subject matter eligibility of patent claims related to nature, natural phenomena and natural products. This article, published in Medicine Economic News in China, discusses patent eligibility in light of the new memo.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.